PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8790449

QGB: a system for querying sequence database fields and features.

G C Overton·J S Aaronson·J Haas·J Adams
View original source ↗Export metadata ↓

Abstract

We have developed a general system, QGB, for performing complex queries on the information in the DDBJ/EMBL/GenBank databases, including queries over the structural features of sequences implied in the FEATURE TABLE. Queries are formed in a Structured Query Language (SQL)-like syntax with language extensions to support complex types (e.g., sets, ordered sets, and records) appropriate for representing and querying sequence data. A novel aspect of QGB is its ability to deduce missing features and infer relationships among features as a consequence of constructing a parse tree of sequence structure from information described in the FEATURE TABLE. The grammar for the parse tree is implemented in a customized form of the Definite Clause Grammar syntax of the logic programming language Prolog. The logic grammar formalism was chosen because it provides a perspicuous representation for features and constraints, and Prolog provides an execution model for the grammar rules. Construction of the parse tree also identifies inconsistencies and errors in the FEATURE TABLE that can in some cases be corrected automatically and used to generate an augmented version of the table.

Explore related subjects

Base SequenceDatabase Management SystemsDatabases, FactualHemoglobinsHumansInformation Storage and RetrievalKaryotypingMolecular Sequence DataProgramming LanguagesJournal ArticleResearch Support, U.S. Gov't, P.H.S.

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G C Overton, J S Aaronson, J Haas, J Adams. 1994. QGB: a system for querying sequence database fields and features.. https://doi.org/10.1089/cmb.1994.1.3

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2016

miR-503-3p promotes epithelial-mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin.

Although progress in clinical and basic research has significantly increased our understanding of breast cancer, little is known about the molecular mechanism underlying breast cancer metastasis. Identification of effective therapeutic targets to prevent breast cancer metastasis is urgently needed. The function of miR-503-3p has been investigated in other cancers, but its role in breast cancer remains undefined. Here, we found that miR-503-3p was overexpressed in breast cancer tissue and plasma compared with adjacent normal breast tissue and with plasma from healthy individuals. Moreover, we identified miR-503-3p to be an oncogene of breast cancer cell proliferation, migration and invasion. Upregulation of miR-503-3p in breast cancer cells inhibited expression of epithelial-mesenchymal transition (EMT)-related protein SMAD2 and the epithelial marker protein E-cadherin by directly binding to their mRNA 3' untranslated region, whereas increased expression of mesenchymal marker proteins, including vimentin and N-cadherin. Taken together, our findings support a critical role for miR-503-3p in induction of breast cancer EMT and suggest that plasma miR-503-3p may be a useful diagnostic biomarker for breast cancer.

Base Sequence↗
PubMed2003

Identification and characterization of Prp45p and Prp46p, essential pre-mRNA splicing factors.

Through exhaustive two-hybrid screens using a budding yeast genomic library, and starting with the splicing factor and DEAH-box RNA helicase Prp22p as bait, we identified yeast Prp45p and Prp46p. We show that as well as interacting in two-hybrid screens, Prp45p and Prp46p interact with each other in vitro. We demonstrate that Prp45p and Prp46p are spliceosome associated throughout the splicing process and both are essential for pre-mRNA splicing. Under nonsplicing conditions they also associate in coprecipitation assays with low levels of the U2, U5, and U6 snRNAs that may indicate their presence in endogenous activated spliceosomes or in a postsplicing snRNP complex.

Base Sequence↗
PubMed1998

A single nucleotide change in the c-myc internal ribosome entry segment leads to enhanced binding of a group of protein factors.

A 340 nucleotide section of the c- myc 5' untranslated region (UTR) contains an internal ribosome entry segment. We have described previously a mutation in this region of RNA in cell lines derived from patients with multiple myeloma (MM) which exhibit increased expression of c- myc protein by an aberrant translational mechanism. In this study we show by electrophoretic mobility shift assays (EMSA), north-western blotting and UV cross-linking that radiolabelled c- myc 5' UTR RNA transcripts which harbour the mutation cause enhanced binding of cellular proteins. In addition, we also demonstrate that an MM derived cell line possesses an altered repertoire of RNA binding proteins. Our data suggest that the deregulated expression of c -myc in MM could result both from the effect of the mutation and the additional proteins which are present in these cell types.

Base Sequence↗